(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HUTRIGEL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

HUTRIGEL

ST13

US500000079294494

Class

1, 5

Filing

79294494

Registration

6450980

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

08/17/2026

Trademark type

Word

Nice classes

1, 5

Filing date

05/26/2020

Registration date

08/17/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/17/2021

Last transaction

08/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

KR

Examiner

BIFTU, BENIAM

Law office

M80

Current location

TMO LAW OFFICE 117

Holders and representatives

Holders

HLB CELL CO.,LTD

Representatives

Kisuk Lee Harness, Dickey & Pierce, PLC

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Cell growth media for growing cells for use in scientific and research use; biological preparations for scientific or laboratory purposes other than for medical or veterinary use; reagents for scientific purposes; chemical preparations for scientific purposes other than for medical or veterinary use; biological preparations for use in biotechnological product development other than medical or veterinary use; biochemicals for in vitro and in vivo scientific use; reagents for research purposes; reagents for medical research; collagen used as a raw ingredient in the manufacture of cosmetics; collagen peptides for cosmetics; collagen for use as a raw ingredient in the manufacture of cosmetics; protein for use in the manufacture of cosmetics; cells for scientific or laboratory purposes; biological preparations for scientific purposesother than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; biological materialcell culture media for scientific and research use *not for medical or veterinary purposes * ; Biological preparationsextracellular matrix for cell cultures for use in scientific research *not for medical or veterinary purposes * ; biological preparationtype 4 collagen and laminin for bioprinting for industrial use *not for medical or veterinary purposes * ; biological material for bioprintingtype 4 collagen and laminin *not for medical or veterinary purposes *

Class 5

Pharmaceutical preparations for skin care; drug delivery agents in the form of solutiongelpowder that facilitate the delivery of pharmaceutical preparations; medicament formulating agents for promoting wound healing of damaged epithelial tissuesconnective tissuesnervous tissuesdental tissues; biological preparations for medical or veterinary purposesfor the treatment of traumatic woundburnulcercorneal diseasesmucosal and submucosal injuriesnerve injuriesinternal organ injuriestendon and ligament injuriesdental diseases; culture media for medical use; biotechnological preparations for medical purposesbiotechnologically-formed proteins for the treatment of traumatic woundburnulcercorneal diseasesmucosal and submucosal injuriesnerve injuriesinternal organ injuriestendon and ligament injuriesdental diseases; cellular function activating agents for medical purposes; Medicated skin care preparations for medical purposes; collagen for medical purposes; pharmaceutical compositionspharmaceutical preparations for promoting wound healing of damaged epithelial tissuesconnective tissuesnervous tissuesdental tissues; surgical implants comprised of living tissues; Natural biomaterials for tissue restoration for medical purposes; implants comprising living tissue for guided tissue regeneration; implantable materials comprising living tissue for use in guided tissue regeneration; surgical implants comprising living tissuesstem cells; extracellular matrixtype 4 collagenlaminin for medical purposes; Bone void fillers consisting of biological materials for medical purposes; biological preparations for medical purposesfor the treatment of traumatic woundburnulcercorneal diseasesmucosal and submucosal injuriesnerve injuriesinternal organ injuriestendon and ligament injuriesdental diseases; biological tissue cultures for medical purposes; biological tissue culture media for medical purposes

Publications

History of USPTO decisions and trademark events.

37 publications found

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

08/17/2026

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

08/18/2022

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

06/18/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/20/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/31/2022

FIMP

FINAL DISPOSITION PROCESSED

01/31/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

11/17/2021

LIME

LIMITATION FROM THE IB EXAMINED AND ENTERED

10/21/2021

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

10/18/2021

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

10/18/2021

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

09/19/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

08/17/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/01/2021

PUBO

PUBLISHED FOR OPPOSITION

06/01/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/12/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/23/2021

XAEC

EXAMINER'S AMENDMENT ENTERED

04/23/2021

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/23/2021

GNEA

EXAMINERS AMENDMENT E-MAILED

04/23/2021

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/23/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/20/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/20/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/20/2021

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/20/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/20/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/20/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/20/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/20/2021

RFNT

REFUSAL PROCESSED BY IB

11/14/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/24/2020

RFRR

REFUSAL PROCESSED BY MPU

10/24/2020

MAFR

APPLICATION FILING RECEIPT MAILED

10/06/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/02/2020

CNRT

NON-FINAL ACTION WRITTEN

10/01/2020

DOCK

ASSIGNED TO EXAMINER

09/30/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/30/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/24/2020

Continuous trademark protection

Get notified about every new filing that threatens HUTRIGEL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.